You searched for "refractive"

2130 results found

Heidelberg Engineering announces partnership with Hospital Services Ltd for distribution and service in Ireland

Heidelberg Engineering is excited to announce a strategic partnership with Hospital Services Ltd (HSL), which will take over as the exclusive distributor and service provider of the Heidelberg Engineering range of products in the Republic of Ireland, effective 1st July...

Inferior oblique botulinum toxin as a postoperative test

The authors aimed to evaluate the role of inferior oblique (IO) botulinum toxin (BT) injection as a surgical simulator prior to IO myectomy, i.e. preoperative diplopia test using BT. This was a retrospective review in a single centre over a...

BTA as a first-line treatment option for acute acquired comitant esotropia

This study presents results of a single-centre institute use of botulinum toxin A (BTA) as an initial treatment choice for acute acquired comitant esotropia (AACE). This was a prospective observational case series study of 72 patients (49 male, 23 female)...

BT as an effective alternative treatment for small angle consecutive exotropia

In this study, the authors evaluate the efficacy of botulinum toxin A (BTA) as a treatment option for consecutive exotropia. This was a retrospective review of 34 patients; 23 female and 11 male. Age at BTA was a mean of...

Use of reduced volume BT as a treatment option for acute onset comitant esotropia

In this study, the effectiveness and safety of botulinum toxin (BT) for patients with acute acquired comitant esotropia (AACE) and deviation ≤25PD was investigated with comparison of results to conservative prism therapy. Botulinum toxin was undertaken without electromyographic guidance and...

The College of Optometrists calls for shift in detecting and managing glaucoma

The College of Optometrists calls for shift in detecting and managing glaucoma by fully unlocking safe and effective primary care capacity Glaucoma is the second leading cause of irreversible sight loss in the UK and affects over one million people,...

New GIRFT glaucoma guidance – opportunities for improvement through primary eyecare services

Primary eyecare organisations have welcomed the publication of NHS England's Getting It Right First Time (GIRFT) Best Practice Guidance for Glaucoma Services. If implemented by ICBs as intended, the new guidance should mark an important step forward in the delivery...

Reclassifying genetic variants in inherited retinal diseases

The authors present a retrospective study of 142 gene sequence variants from 28 patients with vitreoretinal dystrophies which were re-interpreted based on American College of Medical Genetics and Genomics (ACMG) and Association for Molecular Pathology (AMP) guidelines. Overall, there was...

Glaucoma-NET: a novel way of improving glaucoma management in sub-Saharan Africa

Background Glaucoma is the second most common cause of blindness worldwide [1]. People with untreated glaucoma suffer from irreversible, progressive loss of sight. The disease is characterised by progressive loss of visual field, with pathological cupping of the optic disc...

Glaucoma UK’s World Glaucoma Week campaign to increase awareness of glaucoma risk factors

World Glaucoma Week is an annual initiative which brings health organisation and charities from around the world together to amplify health messages relating to glaucoma and raise awareness of the disease.

New rules on capturing a homeless patient’s address will correct ‘major health inequality’, says the AOP

The Association of Optometrists (AOP) has welcomed an announcement by NHS England, which confirms that patients without a fixed address, including people who are homeless or rough sleeping, have a route to access NHS sight care by proving an alternative address.

Results of corneal cross-linking in very steep corneas

Corneal cross-linking (CXL) has been shown to be a safe and valid treatment option for progressive keratoconus and have shown an arrest of progression with a low failure rate of 0% to 2.8% in mild to moderate keratoconus. A Kmax...